Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvo save search
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -3.0%
H: 2.15%
C: 2.15%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -0.44%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.31%
H: 0.56%
C: -0.17%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.23%
H: 0.28%
C: -0.11%
reach research market
Liberty All-Star Equity Fund November 2023 Monthly Update
Published: 2023-12-13 (Crawled : 18:00) - prnewswire.com
SNEJF | News | $82.28 2.78% 1.1K
|
Consumer Durables
|
| O: -0.26%
H: 3.39%
C: 3.39%
SKX 4 | $56.41 -0.79% 0.0% 5M
|
Consumer Non-Durables
|
| O: 1.19%
H: 1.61%
C: 0.58%
NOW | $713.91 -2.39% -0.13% 1.5M
|
Technology Services
|
| O: -0.79%
H: 0.3%
C: -4.17%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.38%
H: 0.21%
C: -0.53%
IQV | $228.09 0.41% 0.0% 760K
|
Health Services
|
| O: 0.35%
H: 3.61%
C: 1.68%
SWKS 4 | $96.09 -1.57% -1.59% 2.6M
|
Electronic Technology
|
| O: 0.94%
H: 3.45%
C: 3.11%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.26%
H: 0.56%
C: 0.25%
PYPL A | $62.31 0.34% 0.34% 12M
|
Technology Services
|
| O: 1.96%
H: 1.89%
C: -1.7%
ADSK | $216.6 2.83% 2.76% 3.1M
|
Technology Services
|
| O: 0.19%
H: 3.09%
C: 2.32%
AMZN | $174.63 -2.56% -2.63% 54M
|
Retail Trade
|
| O: 0.73%
H: 0.41%
C: -1.67%
update liberty
Novo Nordisk A/S - share repurchase programme
Published: 2023-12-11 (Crawled : 13:30) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.22%
H: 0.68%
C: 0.23%
repurchase
Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
Published: 2023-12-11 (Crawled : 07:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.22%
H: 0.68%
C: 0.23%
drug candidate series therapeutics
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -2.79%
H: 0.62%
C: 0.62%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -2.2%
H: 0.0%
C: -0.27%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.5%
C: 0.5%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.42%
H: 0.67%
C: 0.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.2%
H: 0.55%
C: 0.1%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.08%
H: 1.45%
C: 1.17%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
reach market
Novo Nordisk A/S - share repurchase programme
Published: 2023-12-04 (Crawled : 12:30) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.17%
H: 0.57%
C: 0.35%
repurchase
energyRe Announces $1.2 Billion Capital Raise to Accelerate U.S. Clean Energy Transition
Published: 2023-12-04 (Crawled : 12:30) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.17%
H: 0.57%
C: 0.35%
energy
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Published: 2023-11-28 (Crawled : 12:30) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.93%
H: 0.37%
C: -0.43%
PDSB | $2.64 -8.97% -9.85% 880K
|
Health Technology
|
| O: -3.39%
H: 0.7%
C: -6.49%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: -0.87%
H: 1.19%
C: -0.21%
biotech financial
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-27 (Crawled : 14:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.54%
H: 0.53%
C: -0.96%
repurchase
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
Published: 2023-11-23 (Crawled : 16:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
expansion
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-20 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.11%
H: 2.21%
C: 2.06%
repurchase
Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published: 2023-11-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.37%
H: 1.29%
C: 1.29%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 2.62%
H: 0.67%
C: 0.58%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -3.12%
H: 0.61%
C: -0.46%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.4%
H: 0.38%
C: -2.2%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: 0.0%
companies diabetes study market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-14 (Crawled : 11:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.07%
H: 0.09%
C: -0.5%
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-13 (Crawled : 20:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.07%
H: 0.09%
C: -0.5%
repurchase
Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-13 (Crawled : 12:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.72%
H: 2.53%
C: 1.34%
Novo Nordisk A/S: Semaglutide 2.4 mg (Wegovy®) cardiovascular outcomes data presented at American Heart Association Scientific Sessions and simultaneously published in New England Journal of Medicine
Published: 2023-11-11 (Crawled : 16:20) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
wegovy association sessions heart cardiovascular
Global Glucagon-like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc., AstraZeneca PLC, Sanofi, Novo Nordisk Among Others
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
report astrazeneca global market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-10 (Crawled : 12:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.17%
H: 1.21%
C: 0.99%
Novo Nordisk invests more than 42 billion Danish kroner in expansion of manufacturing facilities in Kalundborg, Denmark
Published: 2023-11-10 (Crawled : 07:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.17%
H: 1.21%
C: 0.99%
expansion
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-07 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.32%
H: 1.23%
C: 0.92%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.